Sample projected revenue from tests alone10 May 2022 14:35
Thanks bigAl67, needed some encouragement.
Prompted me to look some numbers up for the possible early adopter countries below...sorry for not knowing howto tabulate on LSE...
USA Canada UK & NI Germany France Spain Totals
Population (m) 330,252,859 38,434,148 66,465,641 83,129,285 67,422,241 47,329,981 633,034,155
Birth rate (%) 12.5 10.6 12 9.3 11 9.02 64
Births number (m) 41,281,607 4,074,020 7,975,877 7,731,024 7,416,447 4,269,164 72,748,138
Genetically vulnerable (1:500) 82,563 8,148 15,952 15,462 14,833 8,538 145,496
Gentamicin treatments (1.25%) 516,020 50,925 99,698 96,638 92,706 53,365 909,352
@ £80 / test £41,281,607.38 £4,074,020 £7,975,877 £7,731,024 £7,416,447 £4,269,164 **£72,748,138.28**
* https://www.manchester.ac.uk/discover/news/nhs-develops-world-first-bedside-genetic-test-to-prevent-babies-going-deaf/
* https://en.populationdata.net/